Literature DB >> 7042176

Extrapulmonary effects of terbutaline during prolonged administration.

B Bengtsson, P O Fagerstrom.   

Abstract

Hand tremor, heart rate, and electrolyte, plasma (pl) insulin, blood (bl) glucose, and pl terbutaline levels were measured in 11 healthy men during infusion and oral administration of terbutaline. Infusion of terbutaline (250 micrograms) was followed by increases in pl insulin concentration and bl glucose and by a decrease in pl K. Similar metabolic changes were seen on day 1 of oral terbutaline (5 mg x 3). Heart rate was moderately increased by terbutaline over the entire period (13 days) or oral dosing. Hand tremor always increased after terbutaline, but to a lesser degree on days 4 and 13 than after the first oral dose. On day 13 there was a very small increase in pl insulin and no reduction in pl K; bl glucose increased slightly from an elevated basal level. Pl terbutaline was of similar maximum concentrations on days 1 and 13, indicating that the tolerance was mediated through reduced response of the effector organs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042176     DOI: 10.1038/clpt.1982.102

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  16 in total

1.  Comparison of the efficacy and systemic effects of 4 mg and 8 mg formulations of salbutamol controlled release in patients with asthma.

Authors:  B J Lipworth; R A Clark; D P Dhillon; J B Palmer; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Subsensitivity of beta-adrenoceptor responses in asthmatic patients taking regular low dose inhaled salbutamol.

Authors:  B J Lipworth; R A Clark; D P Dhillon; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Beta-adrenoceptor responses to inhaled salbutamol in normal subjects.

Authors:  B J Lipworth; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  High-dose inhaled terbutaline increases muscle strength and enhances maximal sprint performance in trained men.

Authors:  Morten Hostrup; Anders Kalsen; Jens Bangsbo; Peter Hemmersbach; Sebastian Karlsson; Vibeke Backer
Journal:  Eur J Appl Physiol       Date:  2014-08-12       Impact factor: 3.078

5.  The biochemical effects of high-dose inhaled salbutamol in patients with asthma.

Authors:  B J Lipworth; R A Clark; C G Fraser; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  Effect of salbutamol on digoxin pharmacokinetics.

Authors:  M Edner; T Jogestrand; R Dahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 7.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

8.  Bambuterol: dose response study of a new terbutaline prodrug in asthma.

Authors:  N H Holstein-Rathlou; L C Laursen; F Madsen; U G Svendsen; Y Gnosspelius; B Weeke
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Pharmacokinetics of bambuterol in healthy subjects.

Authors:  L Nyberg; J Rosenborg; E Weibull; S Jönsson; B M Kennedy; M Nilsson
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

Review 10.  Pharmacokinetic optimisation of asthma treatment.

Authors:  A M Taburet; B Schmit
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.